NU52PS910292
Cooperative Agreement
Overview
Grant Description
North Carolina Tuberculosis Elimination and Laboratory Cooperative Agreement - North Carolina (NC) is considered a high-incidence TB jurisdiction; in 2023, incidence of TB infection was 2 per 100,000 people, up 31% from 2022.
In recent years, the percentage of cases in NC among non-US born individuals increased from 51% in 2018 to 67% in 2023, reflecting demographic shifts in groups at highest risk for TB, from rural, US-born individuals to non-US born individuals residing in urban centers.
Despite significant successes in TB prevention and control to date, making continued progress toward the U.S. TB elimination goal will require significant ongoing investments in TB control.
The NC TB Program (NC TB) aims to bolster current programming by implementing a comprehensive strategy to quickly diagnose and treat tuberculosis disease; promptly investigate contacts of individuals with infectious TB; and efficiently streamline testing and treatment for LTBI.
A commitment to these aims will reduce TB transmission and minimize the progression of LTBI to active TB disease, while decreasing inequitable access to LTBI/TB testing, treatment, and support resources, and addressing disparities in TB health outcomes.
These goals will be achieved through strategic performance improvement cycles incorporating best practices, guided by set NTIP indicators and reviewed quarterly, combined with focused support for local health departments and jurisdictions, which provide direct care for patients with TB and are the cornerstone of TB control.
In addition to programmatic goals, the NC State Laboratory of Public Health (NCSLPH) will continue to advance testing capabilities in the state and increase efficiency in communications, including implementing routine electronic laboratory reporting; using data informed genotyping and universal susceptibility testing to identify multidrug resistant strains; establishing quick turnaround times for processing specimens; and collaborating with partners to ensure optimal use of laboratory services and a timely flow of information.
In recent years, the percentage of cases in NC among non-US born individuals increased from 51% in 2018 to 67% in 2023, reflecting demographic shifts in groups at highest risk for TB, from rural, US-born individuals to non-US born individuals residing in urban centers.
Despite significant successes in TB prevention and control to date, making continued progress toward the U.S. TB elimination goal will require significant ongoing investments in TB control.
The NC TB Program (NC TB) aims to bolster current programming by implementing a comprehensive strategy to quickly diagnose and treat tuberculosis disease; promptly investigate contacts of individuals with infectious TB; and efficiently streamline testing and treatment for LTBI.
A commitment to these aims will reduce TB transmission and minimize the progression of LTBI to active TB disease, while decreasing inequitable access to LTBI/TB testing, treatment, and support resources, and addressing disparities in TB health outcomes.
These goals will be achieved through strategic performance improvement cycles incorporating best practices, guided by set NTIP indicators and reviewed quarterly, combined with focused support for local health departments and jurisdictions, which provide direct care for patients with TB and are the cornerstone of TB control.
In addition to programmatic goals, the NC State Laboratory of Public Health (NCSLPH) will continue to advance testing capabilities in the state and increase efficiency in communications, including implementing routine electronic laboratory reporting; using data informed genotyping and universal susceptibility testing to identify multidrug resistant strains; establishing quick turnaround times for processing specimens; and collaborating with partners to ensure optimal use of laboratory services and a timely flow of information.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Funding Agency
Place of Performance
North Carolina
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 1793% from $178,443 to $3,378,678.
North Carolina Department Of Health & Human Services was awarded
North Carolina TB Elimination & Lab Cooperation Grant
Cooperative Agreement NU52PS910292
worth $3,378,678
from National Center for HIV, Viral Hepatitis, STD, and TB Prevention in January 2025 with work to be completed primarily in North Carolina United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.940 HIV Prevention Activities Health Department Based.
The Cooperative Agreement was awarded through grant opportunity Tuberculosis Elimination and Laboratory Cooperative Agreement.
Status
(Ongoing)
Last Modified 7/6/26
Period of Performance
1/1/25
Start Date
12/31/29
End Date
Funding Split
$3.4M
Federal Obligation
$0.0
Non-Federal Obligation
$3.4M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for NU52PS910292
Transaction History
Modifications to NU52PS910292
Additional Detail
Award ID FAIN
NU52PS910292
SAI Number
NU52PS910292-223887161
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
State Government
Awarding Office
75CDC1 CDC Office of Financial Resources
Funding Office
75CVJ0 CDC NATIONAL CENTER FOR HIV/AIDS, VIRAL HEPATITIS, STD, AND TUBERCULOSIS PREVENTION
Awardee UEI
DKT3LLBWFVL3
Awardee CAGE
1W8J9
Performance District
NC-90
Senators
Thom Tillis
Ted Budd
Ted Budd
Modified: 7/6/26